DUTASTERIDE TEVA

Nazione: Israele

Lingua: inglese

Fonte: Ministry of Health

Principio attivo:

DUTASTERIDE

Commercializzato da:

TEVA ISRAEL LTD

Codice ATC:

G04CB02

Forma farmaceutica:

CAPSULES SOFT

Composizione:

DUTASTERIDE 0.5 MG

Via di somministrazione:

PER OS

Tipo di ricetta:

Required

Prodotto da:

TEVA ISRAEL LTD, ISRAEL

Area terapeutica:

DUTASTERIDE

Indicazioni terapeutiche:

Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.

Data dell'autorizzazione:

2023-04-30

Foglio illustrativo

PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
)PREPARATIONS(
– 1986
The medicine is dispensed with
a doctor’s prescription only
DUTASTERIDE TEVA
SOFT CAPSULES
EACH SOFT CAPSULE CONTAINS:
DUTASTERIDE 0.5 MG
For a list of inactive ingredients, see
section 6 – “Further Information”.
READ THE LEAFLET CAREFULLY IN ITS
ENTIRETY BEFORE USING THE MEDICINE.
This leaflet contains concise
information about the medicine. If you
have further questions, refer to the
doctor or pharmacist.
This medicine has been prescribed for
you. Do not pass it on to others. It may
harm them even if it seems to you that
their medical condition is similar.
This medicine is intended for men only.
1. WHAT
IS
THE
MEDICINE
INTENDED FOR?
- For treatment of moderate to severe
symptoms of benign prostatic
hyperplasia )BPH(.
- To reduce the risk of acute urinary
retention )AUR( and surgery in
patients with moderate to severe
symptoms of benign prostatic
hyperplasia )BPH(.
DUTASTERIDE TEVA IS USED TO TREAT
MEN WITH AN ENLARGED PROSTATE
GLAND )
benign prostatic hyperplasia
( –
a noncancerous tumor of the prostate
gland, caused by overproduction of a
hormone called dihydrotestosterone.
Enlargement of the prostate gland
can lead to urinary system problems,
such as difficulty in passing urine and
frequent need to go to the bathroom.
Likewise, it may slow and weaken the
urine flow. If left untreated, there is risk
that your urine flow will become fully
blocked )
acute urinary retention
(. This
condition requires immediate medical
treatment. In certain cases, there is a
need to surgically remove or reduce
the size of the prostate. Dutasteride
Teva reduces the production of
dihydrotestosterone, thereby helping
reduce the size of the prostate and
relieving symptoms. This will reduce
the risk of acute urinary retention and
the need for surgery.
Dutasteride Teva can also be used with
another medicine called tamsulosin
)used to treat symptoms of an enlarged
prostate gland(.
THERAPEUTIC GROUP
5-alpha-reductase enzyme inhibitor